Literature DB >> 18632017

Attitudes of GPs to the diagnosis and management of impaired glucose tolerance: the practitioners' attitudes to hyperglycaemia (PAtH) questionnaire.

J D G Fearn-Smith1, P H Evans, G Harding, J L Campbell.   

Abstract

AIMS: To develop and pilot a survey instrument assessing general practitioners' (GP) attitudes to the diagnosis and management of one form of pre-diabetes, impaired glucose tolerance (IGT) and to assess the performance of the questionnaire.
METHODS: Qualitative data together with an audit were used to generate questionnaire items, which were then subjected to a process of pre-piloting and piloting to generate a finalised item list. The pilot questionnaire was sent to 222 principal GPs in three PCTs in South West England. The first fifty responders were asked to complete the questionnaire again 2 weeks later. Principal components analysis with a Varimax rotation was used to detect latent factors within the data that may help to explain the attitudes of GPs.
RESULTS: The response rate after one reminder was 54.1%. Four robust factors were identified which were internally consistent (range of Cronbach's alpha=0.79-0.65), homogeneous (item-total correlations=0.60-0.21), and stable (test-retest correlation=0.74-0.58) accounting for 31.1% of the variance. The predictive validity of the item list was assessed (P=0.02 for factor 1).
CONCLUSIONS: The PAtH questionnaire identifies four factors that help to describe GPs attitudes to the diagnosis and management of IGT.

Entities:  

Mesh:

Year:  2006        PMID: 18632017     DOI: 10.1016/j.pcd.2006.07.003

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  2 in total

1.  Supporting self-care in general practice.

Authors:  Colin J Greaves; John L Campbell
Journal:  Br J Gen Pract       Date:  2007-10       Impact factor: 5.386

2.  Barriers to sexual health care: a survey of Iranian-American physicians in California, USA.

Authors:  Mitra Rashidian; Victor Minichiello; Synnove F Knutsen; Mark Ghamsary
Journal:  BMC Health Serv Res       Date:  2016-07-15       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.